Terms: = Lung cancer AND GPC3, OCI-5, 2719, ENSG00000147257, SGBS, SGB, DGSX, SDYS, P51654, AC002420_1, SGBS1
57 results:
1. Postoperative stellate ganglion block to reduce myocardial injury after laparoscopic radical resection for colorectal cancer: protocol for a randomised trial.
Hu Z; Li W; Zhao G; Liang C; Li K
BMJ Open; 2023 Nov; 13(11):e069183. PubMed ID: 37977873
[TBL] [Abstract] [Full Text] [Related]
2. gpc3 Promotes lung Squamous Cell Carcinoma Progression and HLA-A2-Restricted gpc3 Antigenic Peptide-Modified Dendritic Cell-Induced Cytotoxic T Lymphocytes to Kill lung Squamous Cell Carcinoma Cells.
Ning J; Ding J; Wang S; Jiang Y; Wang D; Jiang S
J Immunol Res; 2023; 2023():5532617. PubMed ID: 37965271
[TBL] [Abstract] [Full Text] [Related]
3. Biological and clinical significance of the glypican-3 gene in human lung adenocarcinoma: An in silico analysis.
Imon RR; Aktar S; Morshed N; Nur SM; Mahtarin R; Rahman FA; Talukder MEK; Alam R; Karpiński TM; Ahammad F; Zamzami MA; Tan SC
Medicine (Baltimore); 2023 Nov; 102(45):e35347. PubMed ID: 37960765
[TBL] [Abstract] [Full Text] [Related]
4. The Role of microRNAs in Regulating cancer Cell Response to Oxaliplatin-Containing Regimens.
Tavakoli Pirzaman A; Ebrahimzadeh Pirshahid M; Babajani B; Rahmati A; Niknezhad S; Hosseinzadeh R; Taheri M; Ebrahimi-Zadeh F; Doostmohamadian S; Kazemi S
Technol Cancer Res Treat; 2023; 22():15330338231206003. PubMed ID: 37849311
[TBL] [Abstract] [Full Text] [Related]
5. H1Innovative approaches to combat anti-cancer drug resistance: Targeting lncRNA and autophagy.
Zhong C; Xie Z; Duan S
Clin Transl Med; 2023 Oct; 13(10):e1445. PubMed ID: 37837401
[TBL] [Abstract] [Full Text] [Related]
6. Non-coding RNAs in cancer immunotherapy: Predictive biomarkers and targets.
Alahdal M; Elkord E
Clin Transl Med; 2023 Sep; 13(9):e1425. PubMed ID: 37735815
[TBL] [Abstract] [Full Text] [Related]
7. Clinicopathological features and differential diagnosis of gastric metastases.
Chen W; Liu C; Liu Y; Yuan J; Wang Z
World J Surg Oncol; 2023 Aug; 21(1):258. PubMed ID: 37608278
[TBL] [Abstract] [Full Text] [Related]
8. Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer.
Lee NY; Hum M; Zihara S; Wang L; Myint MK; Lim DW; Toh CK; Skanderup A; Samol J; Tan MH; Ang P; Lee SC; Tan EH; Lai GGY; Tan DSW; Yap YS; Lee ASG
Hum Genomics; 2023 Jul; 17(1):66. PubMed ID: 37461096
[TBL] [Abstract] [Full Text] [Related]
9. Silicosis, asbestosis, and pulmonary fibrosis in Ontario, Canada from 1996 to 2019.
Zhang Y; Rajaram N; Lau A; Mehta K; Holness DL; Tarlo SM; Arrandale VH
Am J Ind Med; 2023 Aug; 66(8):670-678. PubMed ID: 37302125
[TBL] [Abstract] [Full Text] [Related]
10. Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3-Expressing Liver cancer by Immuno-PET.
Fayn S; King AP; Gutsche NT; Duan Z; Buffington J; Olkowski CP; Fu Y; Hong J; Sail D; Baidoo KE; Swenson RE; Cheloha RW; Ho M; Choyke PL; Escorcia FE
J Nucl Med; 2023 Jul; 64(7):1017-1023. PubMed ID: 36997331
[TBL] [Abstract] [Full Text] [Related]
11. Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior.
Cheng F; Hansson VC; Georgolopoulos G; Mani K
Oncotarget; 2023 Mar; 14():219-235. PubMed ID: 36944188
[TBL] [Abstract] [Full Text] [Related]
12. Trends in Survival Rates of Non-Small Cell lung cancer With Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020.
Chi SA; Yu H; Choi YL; Park S; Sun JM; Lee SH; Ahn JS; Ahn MJ; Choi DH; Kim K; Jung HA; Park K
JAMA Netw Open; 2023 Mar; 6(3):e232002. PubMed ID: 36929402
[TBL] [Abstract] [Full Text] [Related]
13. Discovery of potential biomarkers for lung cancer classification based on human proteome microarrays using Stochastic Gradient Boosting approach.
Yao N; Pan J; Chen X; Li P; Li Y; Wang Z; Yao T; Qian L; Yi D; Wu Y
J Cancer Res Clin Oncol; 2023 Aug; 149(10):6803-6812. PubMed ID: 36807761
[TBL] [Abstract] [Full Text] [Related]
14. A clinically feasible circulating tumor cell sorting system for monitoring the progression of advanced hepatocellular carcinoma.
Huang XY; Li F; Li TT; Zhang JT; Shi XJ; Huang XY; Zhou J; Tang ZY; Huang ZL
J Nanobiotechnology; 2023 Jan; 21(1):25. PubMed ID: 36681851
[TBL] [Abstract] [Full Text] [Related]
15. [Ultrasound-guided stellate ganglion block improves sleep quality in elderly patients early after thoracoscopic surgery for lung cancer: a randomized controlled study].
Gu C; Zhai M; Lü A; Liu L; Hu H; Liu X; Li X; Cheng X
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1807-1814. PubMed ID: 36651248
[TBL] [Abstract] [Full Text] [Related]
16. Identification of an inflammatory response signature associated with prognostic stratification and drug sensitivity in lung adenocarcinoma.
Song C; Lu Z; Lai K; Li D; Hao B; Xu C; Pan S; Li N; Geng Q
Sci Rep; 2022 Jun; 12(1):10110. PubMed ID: 35710585
[TBL] [Abstract] [Full Text] [Related]
17. BOXR1030, an anti-gpc3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved anti-cell line derived tumor xenograft activity.
Hickman TL; Choi E; Whiteman KR; Muralidharan S; Pai T; Johnson T; Parikh A; Friedman T; Gilbert M; Shen B; Barron L; McGinness KE; Ettenberg SA; Motz GT; Weiss GJ; Jensen-Smith A
PLoS One; 2022; 17(5):e0266980. PubMed ID: 35507536
[TBL] [Abstract] [Full Text] [Related]
18. An Inflammation-Related Nine-Gene Signature to Improve Prognosis Prediction of lung Adenocarcinoma.
Liu ZJ; Hou PX; Wang XX
Dis Markers; 2021; 2021():9568057. PubMed ID: 34580602
[TBL] [Abstract] [Full Text] [Related]
19. gpc3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma.
Ning J; Jiang S; Li X; Wang Y; Deng X; Zhang Z; He L; Wang D; Jiang Y
BMC Pulm Med; 2021 Jun; 21(1):199. PubMed ID: 34112123
[TBL] [Abstract] [Full Text] [Related]
20. Decreased HLF Expression Predicts Poor Survival in lung Adenocarcinoma.
Wang Z; Li X; Chen H; Han L; Ji X; Wang Q; Wei L; Miao Y; Wang J; Mao J; Zhang Z
Med Sci Monit; 2021 May; 27():e929333. PubMed ID: 33979320
[TBL] [Abstract] [Full Text] [Related]
[Next]
